James A. Zwiebel

Combined DNA Methyltransferase and Histone Deacetylase Inhibition in the Treatment of Myeloid Neoplasms

Steven D. Gore, Stephen B. Baylin, Elizabeth A. Sugar et al. · Cancer Research · 2006 · 472 citations · Full text

A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting

E. Antonio Chiocca, Khalid M. Abbed, Stephen B. Tatter et al. · Molecular Therapy · 2004 · 434 citations · Full text

Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma

Qin Ryan, Donna Headlee, Milin Acharya et al. · Journal of Clinical Oncology · 2005 · 406 citations · Full text

Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results

Frederick F. Lang, Janet M. Bruner, Gregory N. Fuller et al. · Journal of Clinical Oncology · 2003 · 391 citations

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Evanthia Galanis, Kurt A. Jaeckle, Matthew J. Maurer et al. · Journal of Clinical Oncology · 2009 · 354 citations · Full text